About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

American Scientists Successfully Develop Treatment for Ebola Infections

by Mansi Shroff on April 24, 2015 at 11:24 AM
Font : A-A+

American Scientists Successfully Develop Treatment for Ebola Infections

A team of researchers has successfully developed a treatment that has resulted effective against a specific strain of the Ebola virus.

Researchers from the University of Texas Medical Branch at Galveston and Tekmira Pharmaceuticals Corp., demonstrated that the treatment is the first to be shown effective against the new Makona outbreak strain of Ebola in animals that were infected with the virus and exhibited symptoms of the disease.

Advertisement

The treatment uses a sequence specific short strand of RNA, known as siRNA, designed to target and interfere with the Ebola virus, rendering it harmless. One of the advantages of this approach is the ability to quickly modify it to different viral strains.

Researcher Thomas Geisbert said that they quickly adapted their candidate treatment to target the Makona outbreak strain of Ebola virus and they were able to protect all of their nonhuman primates against a lethal Makona Ebola infection when treatment began three days following infection. At this point, those infected showed clinical signs of disease and had detectable levels of virus in their blood.
Advertisement

Although all infected animals showed evidence of advanced disease, those receiving treatment had milder symptoms and recovered fully. The untreated controls succumbed to the disease on days eight and nine, which is similar to that reported in the field after patients begin showing symptoms of Ebola.

This treatment also protected against liver and kidney dysfunction and blood disorders that occur during an Ebola infection. These results indicate that the treatment may confer protective benefits that go beyond improving survival rates and effective control of virus levels in the body.

The Tekmira siRNA-based therapeutic is now being evaluated in Ebola-infected patients in Sierra Leone.

The study appears in the Nature Journal.

Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Ways to Manage Stress during COVID-19 Pandemic
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Congo Fever Ebola Virus Disease 

Recommended Reading
Ebola Virus Disease
Ebola is caused by a virus via direct contact with body fluids or infected blood. Scientists have .....
World Support for Ebola: US$35 Million Funding from King Abdallah of Saudi Arabia
Zaire ebolavirus is commonly known as Ebola. It was previously known as ebola haemorrhagic fever ......
Liberia Reports First Ebola Infection After a Month
After suffering over 4,000 deaths due to the deadly virus, Liberia was supposed to be declared ......
Govts Must Launch Health Campaigns on a Massive Scale to Create Awareness on Epidemics
Nobody can predict the next big epidemic but we can create better healthcare facilities so that ......
Congo Fever
Crimean-Congo Hemorrhagic fever (CCHF) is a viral disease that affects people who are bitten by infe...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use